HOME >> BIOLOGY >> NEWS
Vaccine shown effective against chancroid

CHAPEL HILL HIV plagues more than 25 million people in sub-Saharan Africa, according to the World Health Organization, and efforts to develop a vaccine against the virus have achieved limited success.

But what if a vaccine against another sexually transmitted infection found widely in that region of Africa chancroid was relatively easy to develop and could reduce transmission of HIV as much as 10-fold?

That may be the case, according to researchers from the University of North Carolina at Chapel Hill's School of Medicine and N.C. State University's College of Veterinary Medicine.

Their study appears in the April issue of the journal Infection and Immunity. The lead author is Dr. Galyna Afonina, postdoctoral research associate in the UNC Center for Infectious Diseases. Senior author is Dr. Christopher Elkins, research associate professor in the departments of medicine and microbiology and immunology in UNC's School of Medicine.

Chancroid, a sexually transmitted disease that causes genital ulcers, is rare in the United States but takes hold in communities that have little or no access to health care, such as in Africa. Recent studies show that genital ulcer diseases such as chancroid can enhance HIV transmission three- to 10-fold.

"There is considerable evidence that genital ulcers are independent risk factors for the transmission of HIV, and chancroid may be the most important one," said Elkins.

Chancroid is caused by a bacterium, Haemophilus ducreyi, that normally infects only humans. Unlike most bacteria, Haemophilus species are unable to synthesize heme, the ferrous, or iron-containing, component of hemoglobin, and obtain it from host hemoglobin.

The researchers found that immunizing swine with a purified hemoglobin receptor protected the animals from a challenge infection, even after multiple attempts at infection.

Blood tests showed that the immunized pigs formed antibodies that prevented the chancroid bacteria from
'"/>

Contact: Leslie H. Lang
llang@med.unc.edu
919-843-9687
University of North Carolina School of Medicine
5-May-2006


Page: 1 2 3

Related biology news :

1. Vaccine trials inject hope into koalas future
2. Vaccine hope for malaria
3. Vaccine prevents prion disease in mice
4. Vaccine hope for sufferers of potentially fatal stomach bug
5. Vaccine to cope with viral diversity in HIV
6. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
7. U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication
8. Vaccine-producing plant-factories
9. HPV Vaccine: Whats next
10. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
11. Vaccine provides 100 percent protection against avian flu virus in animal study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2020)... ... February 04, 2020 , ... Crystal ... the company a second patent related to proprietary liquid crystal technology for rapid ... patent from the USPTO issued on December 3, 2019. Together, these patents protect ...
(Date:1/29/2020)... ... 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), the recognized ... a record earnings year for 2019. With final numbers to be released to ... increase in revenue and a thirty percent increase in gross profit, and more ...
(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus Therapeutics Inc. today ... tech entrepreneur, and former senior management consultant at McKinsey & Company who holds ... alternative investment firm. , “Chris Thorne has exceptional business acumen with a ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal ... cosmetic surgery industry at two recent North American investor forums specializing in medical ... Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 in New York ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies ... Genome editing. The partners have agreed to co-develop and market a portfolio of ... and pre-clinical programs. Over the longer-term, the parties aim to develop a COBO ...
(Date:1/10/2020)... (PRWEB) , ... January 09, 2020 , ... ... and expert services, today announced the acquisition of Cunesoft, a move that expands ... the business objectives of life sciences companies. , Based in Munich, Germany, Cunesoft ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... care helps couples and individuals grow their family, has announced that five of ... by Castle Connolly. Since 1991, the renowned publishing company Castle Connolly ...
Breaking Biology Technology:
Cached News: